Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01)
קרן | National Institute of Diabetes and Digestive and Kidney Diseases/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 26/02/2019 |
פקולטה | Life Sciences, Medicine |
תיאור | This grant solicits applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through the controlled manipulation of beta cell replication, islet cell plasticity, and the reprogramming of pancreatic non-beta cells into beta-like cells, or through shielding the residual beta cell mass from the autoimmune environment.
Funding: $550,000 per year Duration: 4 years
Research Authority due date: 20.1.19 LOI (encouraged) due date: 26.1.19 Full proposal due date: 26.2.19
|
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 01/11/2018 |